Business Parks & Science Centres

 
 
 

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
All > Germany >

News > Western Germany

Find below news from the Western German Federal States of Hessen, Nordrhein-Westfalen, Rheinland-Pfalz and Saarland. Listed are news about this region as well as from organisations located there.

Total search results: 2255 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne. 2019-04-16
MLM Medical Labs GmbH. (4/15/19). "Press Release: Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project to Enable Development and Implementation of Novel Safety Biomarkers". Mönchengladbach. 2019-04-15
Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. 2019-04-08
Phenex Pharmaceuticals AG. (4/5/19). "Press Release: Phenex Collaborates with Mathias Heikenwälder’s Research Group from DKFZ (German Cancer Research Center)". Ludwigshafen. 2019-04-05
Probiodrug AG. (4/4/19). "Press Release: Probiodrug AG has Mandated Oddo Seydler Bank AG as Designated Sponsor. The Shares Are Trading on XETRA, the Electronic Trading Platform of Deutsche Börse". Halle (Saale). 2019-04-04
Qiagen N.V.. (4/3/19). "Press Release: Qiagen and LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals". Hilden & Germantown, MD. 2019-04-03
Qiagen N.V.. (3/28/19). "Press Release: Qiagen Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research". Germantown, MD & Hilden. 2019-03-28
ProteoNic Biotechnology B.V.. (3/28/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Bayer". Leiden. 2019-03-28
Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". 2019-03-26
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
SilverSky LifeSciences GmbH. (3/18/19). "Press Release: DxPx – The First International Diagnostics Partnering Conference". Düsseldorf. 2019-03-18
Merck KGaA. (3/14/19). "Press Release: Merck Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-03-14
Boehringer Ingelheim. (3/7/19). "Press Release: Novel Antibody Shows Potential to Transform Treatment of Rare Form of Psoriasis". Ingelheim. 2019-03-07
Merck KGaA. (3/5/19). "Press Release: Open Letter to Versum Shareholders from Merck". Darmstadt. 2019-03-05
Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt. 2019-03-04
Evotec AG. (2/28/19). "Press Release: Evotec Receives Milestone Payment for Start of Second Phase II Trial in Its Muli-target Alliance with Bayer". Hamburg. 2019-02-28
Merck KGaA. (2/27/19). "Press Release: Merck Submits All-Cash Proposal to Acquire Versum. $48 Per Share Proposal Represents a Premium to Current Value of Entegris’ All-Stock Proposal". Darmstadt. 2019-02-27
Boehringer Ingelheim. (2/25/19). "Press Release: New Chief Medical Officer Appointed". Ingelheim. 2019-02-25
BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen. 2019-02-20
Merck KGaA. (2/19/19). "Press Release: Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method". Darmstadt. 2019-02-19
Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & 2019-02-16
Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. 2019-02-15
BioMed X GmbH. (2/14/19). "Press Release: Merck and BioMed X Expand Collaboration to Immunology Research". Heidelberg. 2019-02-14
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. 2019-02-12
Merck KGaA. (2/11/19). "Press Release: FDA Accepts sBLA and Grants Priority Review for Bavencio (avelumab) plus Inlyta (axitinib) for the Treatment of Advanced Renal Cell Carcinoma [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-02-11
Lonza Group AG. (2/11/19). "Press Release: Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability". Walkersville, MD & Basel. 2019-02-11
Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". 2019-02-11
Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. 2019-02-04
Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Partners with AMPATH to Scale Up Knowledge, Skills and Training for Healthcare Providers in Kenya". Ingelheim. 2019-01-24
Merck KGaA. (1/24/19). "Press Release: Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors [Not intended for UK- or US-based media]". Darmstadt. 2019-01-24
BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. 2019-01-23
Merck KGaA. (1/23/19). "Press Release: Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China". Chengdu. 2019-01-23
Grünenthal GmbH. (1/22/19). "Press Release: Fabian Raschke Appointed Chief Financial Officer (CFO)". Aachen. 2019-01-22
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. 2019-01-17
Boehringer Ingelheim. (1/17/19). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Expands Commercial Manufacturing Capacities". Shanghai. 2019-01-17
Miltenyi Biotec GmbH. (1/17/19). "Press Release: Miltenyi Biotec Acquires Promising Non-harmful Imaging Process". Bergisch Gladbach. 2019-01-17
Merck KGaA. (1/16/19). "Press Release: Merck Welcomes Ten New Startups to Its Innovation Center". Darmstadt. 2019-01-16
Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo. 2019-01-16
High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". 2019-01-16
Bioharmony Therapeutics, Inc.. (1/15/19). "Press Release: Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections". New York, NY. 2019-01-15
Qiagen N.V.. (1/7/19). "Press Release: Qiagen Acquires N-of-One, Expanding Its Clinical Bioinformatics Capabilities in Molecular Oncology Decision Support". Redwood City, CA & Hilden. 2019-01-07
Boehringer Ingelheim. (1/4/19). "Press Release: Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna". Ingelheim & Cambridge, MA. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". 2019-01-04
Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. 2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA. 2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim. 2019-01-03
High-Tech Gründerfonds Management GmbH. (12/18/18). "Press Release: High-Tech Gründerfonds and Think.Health Ventures together with Business Angels Invest 3.3 Million Euros in a Series A for the Growth of PreOmics in Martinsried, Germany". 2018-12-18
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
BRAIN AG. (12/14/18). "Press Release: BRAIN Achieves Double-digit Growth in Total Operating Performance and Revenues in the 2017/18 Financial Year". Zwingenberg. 2018-12-14
Lead Discovery Center GmbH. (12/13/18). "Press Release: LDC and the University of Duisburg-Essen Receive EUR 905,000 for the Development of New Therapies for Age-related Blindness". Dortmund. 2018-12-13
High-Tech Gründerfonds Management GmbH. (12/11/18). "Press Release: High-Tech Gründerfonds and Technologiegründerfonds Sachsen Support Enabling Human Biology in vitro with an Investment in Dresden Start-up DenovoMatrix". 2018-12-11
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt. 2018-12-06
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Protagen AG. (12/4/18). "Press Release: The EORTC Brain Tumor Group and Protagen AG Announce Their Collaboration to Investigate the Immuno-competence of Long-term Glioblastoma Survivors". 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto. 2018-11-26
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
BRAIN AG. (11/21/18). "Press Release: Manfred Bender Set to Join BRAIN AG’s Management Board as Chief Financial Officer (CFO)". Zwingenberg. 2018-11-21
Merck KGaA. (11/19/18). "Press Release: Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer [Not intended for US, Canada and UK-based media]". Darmstadt. 2018-11-19
Merck KGaA. (11/19/18). "Press Release: Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer. Joint Venture between Merck and Palantir Technologies Being Created to Advance Cancer Research". Palo Alto, CA. 2018-11-19
Boehringer Ingelheim. (11/15/18). "Press Release: Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies". Cambridge, MA & Ingelheim. 2018-11-15
Merck KGaA. (11/12/18). "Press Release: Merck Paves the Way for Its Innovation Hub in Southern China". Darmstadt & Guangzhou. 2018-11-12
Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. 2018-11-12
BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz. 2018-11-05
Boehringer Ingelheim. (11/5/18). "Press Release: Initial Results from EMPRISE Real-world Evidence Study". Ingelheim & Indianapolis, IN. 2018-11-05
Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. 2018-10-30
Noscendo GmbH. (10/29/18). "Press Release: Noscendo Closes Financing Round for CE Certification and Market Entry Preparation of Platform Diagnostics for Bloodstream Associated Infections". Duisburg. 2018-10-29
Boehringer Ingelheim. (10/26/18). "Press Release: Boehringer Ingelheim Inaugurates New Centre for Agile Working Methods – More and Better Health Solutions for Humans and Animals". Ingelheim. 2018-10-26
Boehringer Ingelheim. (10/19/18). "Press Release: Real-world Study Shows Using Giotrif/Gilotrif (afatinib) Followed by Osimertinib Provides a Median of 27.6 Months of Chemotherapy-free Time in Patients with EGFR Mutation-positive NSCLC". Ingelheim. 2018-10-19
Protagen AG. (10/18/18). "Press Release: The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend Their Collaboration to Investigate the Immuno-competence of Urothelial Cancer Patients Receiving Immunotherapy". 2018-10-18
Miltenyi Biotec GmbH. (10/12/18). "Press Release: Miltenyi Biotec Acquires Microscopy Specialist LaVision BioTec". Bergisch Gladbach & Bielefeld. 2018-10-12
Qiagen N.V.. (10/11/18). "Press Release: Qiagen Launches Novel RNA-seq Library Preparation Solutions for Next-generation Sequencing". Hilden & Germantown, MD. 2018-10-11
BRAIN AG. (10/10/18). "Press Release: Ludger Roedder to join BRAIN AG Management Board as Chief Business Officer (CBO)". Zwingenberg. 2018-10-10
Forbion Capital Partners. (10/1/18). "Press Release: Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 Million". Naarden & Munich. 2018-10-01
Taros Chemicals GmbH & Co. KG. (10/1/18). "Press Release: Taros Appoints Torsten Hoffmann as Senior Vice President Drug Discovery". Dortmund. 2018-10-01
AiCuris Anti-infective Cures GmbH. (10/1/18). "Press Release: AiCuris to Cooperate with Cyclenium Pharma to Develop Novel Anti-Infectives". Wuppertal & Montreal. 2018-10-01
Qiagen N.V.. (9/28/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-09-28
Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel. 2018-09-27
Celyad S.A.. (9/26/18). "Press Release: Celyad Appoints Carri Duncan as Vice-President Corporate Development and Communications". Mont-Saint-Guibert. 2018-09-26
BCNP Consultants GmbH. (9/26/18). "Press Release: Over 600 Partnering Discussions at the First European Chemistry Partnering Summer Summit". Düsseldorf. 2018-09-26
Protagen AG. (9/25/18). "Press Release: NEC Laboratories Europe GmbH, the National Center for Tumor Diseases and Protagen AG Collaborate to Improve Information Integration and Artificial Intelligence for Better Therapy Decisions in Immuno-Oncology". 2018-09-25
Apeiron Biologics AG. (9/19/18). "Press Release: Apeiron Announces Collaboration with Lead Discovery Center GmbH". Vienna. 2018-09-19
BRAIN AG. (9/18/18). "Press Release: BRAIN AG Announces Strategic Research Collaboration with BluCon Biotech GmbH". Zwingenberg & Cologne. 2018-09-18
ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. 2018-09-13
Boehringer Ingelheim. (9/12/18). "Press Release: Biosimilar Cyltezo Demonstrates Clinical Equivalence to Humira in Patients with Moderate-to-Severe Plaque Psoriasis". Ingelheim. 2018-09-12
Qiagen N.V.. (9/12/18). "Press Release: Qiagen to Join Germany’s MDAX Index in Addition to TecDAX". Hilden & Germantown, MD. 2018-09-12
Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. 2018-09-10
Evotec AG. (9/6/18). "Press Release: Evotec AG Listed in MDAX". Hamburg. 2018-09-06
MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. 2018-09-06
Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. 2018-09-06
AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. 2018-09-03
BRAIN AG. (8/31/18). "Press Release: BRAIN AG Reports Growth for the First Nine Months of the 2017/18 Financial Year". Zwingenberg. 2018-08-31
EMD Serono. (8/31/18). "Press Release: Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America". Rockland, MA. 2018-08-31
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top